Introduction 1,3-butadiene (BD) is used extensively in the production of polymers and synthetic rubber and has also been detected in exhaust and cigarette smoke (IARC, 1992) . Epidemiological ®ndings from the synthetic rubber industry indicate an association between occupational exposure to BD and the development of lymphatic and hematopoietic cancers (Divine, 1990; Matanoski et al., 1990) . 2',3'-dideoxycytidine (ddC) is a synthetic pyrimidine nucleoside analogue approved for treatment of human immunode®ciency virus (HIV) positive patients. Cancer bioassays in mice have shown that both BD and ddC are carcinogenic and induce a high frequency of lymphomas in mice (Melnick et al., 1990; Rao et al., 1996) .
The p16
INK4a
and p15
INK4b
genes were recently identi®ed and mapped to human chromosome 9p21 (Serrano et al., 1993; Hannon and Beach, 1994) , a region frequently aected by homozygous deletion or loss of heterozygosity (LOH) in a variety of malignancies (Cairns et al., 1995) . The p16
INK4a gene yields two transcripts that encode p16 and p19 ARF proteins respectively. These two transcripts are derived from alternative ®rst exons, E1a and E1b, each of which is joined to exon 2 through the same splice acceptor site in an alternative reading frame Quelle et al., 1995a; Stone et al., 1995) . The reading frame encoding p16 is designated as p16
INK4a
-a and the one encoding p19 ARF as p16
-b (Quelle et al., 1995a; Herzog et al., 1996) . It is known that p16 negatively regulates G1 to S phase transition of the cell cycle by inhibiting the function of the CDK4 and CDK6 cyclin-dependent kinases in a pRb-dependent manner (Serrano et al., 1993; Lukas et al., 1995; Koh et al., 1995; Medema et al., 1995) . Because of its ability to block G1/S progression, p16 is believed to function as a tumour suppressor. This hypothesis is supported by the observations that p16 is inactivated in a variety of human tumours (Kamb et al., 1994; Nobori et al., 1994; Okamoto et al., 1994; Cairns et al., 1995; Hirama and Koeer, 1995) and inherited p16
INK4a mutant alleles predipose individuals to the development of malignant melanoma and pancreatic adenocarcinoma (Hussussian et al., 1994; Goldstein et al., 1995; Whelan et al., 1995) . Furthermore, direct evidence that p16 de®ciency facilitates tumour development is provided through the generation of p16 INK4a 7/7 mice by gene targeting (Serrano et al., 1996) . These p16-de®cient mice develop normally but are particularly susceptible to lymphoma and sarcoma formation. Three mechanisms to inactivate p16 have been characterized so far. These include point mutation, homozygous deletion and hypermethylation of CpG island spanning the promoter region (Koh et al., 1995; Merlo et al., 1995; Yang et al., 1995; Lilischkis et al., 1996; Arap et al., 1997). p19 ARF is totally unrelated to p16 in its protein sequence, but may also arrest the cell cycle in both G1 and G2 phases. Interestingly, p19
ARF does not bind to several CDK family members and it appears to function independently of p16 (Quelle et al., 1995a) and pRb (Liggett et al., 1996) . Thus, p19 ARF might act downstream of pRb or in a distinct parallel pathway (Liggett et al., 1996) . p15 especially in lymphoid malignancies (Rasool et al., 1995; Sibert et al., 1995; Heyman et al., 1996; Herman et al., 1997) .
The murine counterparts of the human p16 INK4a and p15
INK4b genes were mapped to position C3-C6 on mouse chromosome 4, a region syntenic with human chromosome 9p21-22 (Quelle et al., 1995b) . The loss of genetic markers in this region and involvement of p16 and p15 have been implicated in the development of dierent types of murine malignancies (Herzog et al., 1994; Linardopoulos et al., 1995; Zhuang et al., 1996; Malumbres et al., 1997) . In this work, we investigated the genetic status of p16
INK4a (a and b forms) and p15
INK4b in both BD-and ddC-induced lymphomas of B6C3F1 mice. Our results reveal that alterations of p16
-b and p15
INK4b are common in ddC-induced lymphomas but not BD-induced lymphomas and support a tumour suppressor role for both p19 ARF and p15.
Results

Homozygous deletion of the p16 INK4a and p15 INK4b genes
Since homozygous deletion is a common mechanism to inactivate the p16 INK4a and p15 INK4b genes, tumour DNAs from ddC-and BD-induced lymphomas were digested with BamHI and subjected to Southern analysis with probes speci®c for E1a, E1b and exon 2 of p16
INK4a and both exon 1 and 2 of p15
INK4b
, respectively. Deletions were found in four of 16 ddCinduced lymphomas (25%) but only two of 31 BDinduced lymphomas (6.5%). The BD-induced lymphomas (BLF4 and BLF30) revealed homozygous deletion of major portions of both the p16
INK4a and p15
INK4b genes (Figures 1 and 2 ). However, two of four ddC-induced lymphomas (DLF13 and DLF14) with deletions showed alterations that were exclusive for p16
INK4a E1b. A third tumour (DLF15) showed absence of E1b and a 8 kb band instead of 10.5 kb fragment when the ®lter was hybridized with a p15
INK4b exon 2 probe (Figures 1 and 2 ). Rearrangement of 10.5 kb fragment to a novel band of approximately 8 kb was also found in another tumour (DLF6) when the p15
INK4b exon 2 was used as a probe, while the remaining exons of p16
INK4b genes were retained ( Figure 2 ). The deletion assay in DNA from normal spleen of B6C3F1 mice showed the existence of both p16
genes (data not shown). These results indicate that inactivation of p16 INK4a and p15 INK4b is involved in the development of a signi®cant subset of ddC-and BDinduced lymphomas.
Methylation assay of CpG islands in the promoter region of the p16
INK4a and p15 INK4b genes
Both murine p16 INK4a and p15
INK4b genes contain CpG islands in their ®rst exons and 5' upstream sequences and these regions were recently shown to be hypermethylated in radiation-induced mouse lymphomas (Malumbres et al., 1997) . To investigate whether inactivation of p16 and p15 by hypermethylation plays a role in the development of ddC-and BDinduced lymphomas, methylation-sensitive enzymes XhoI and EagI were employed for Southern analysis of p16
INK4a
-a and p15
INK4b genes, respectively. Hypermethylation of p15
INK4b genes was observed in two of 16 (12.5%) ddC-induced lymphomas (DLF2 and DLF8), whereas hypermethylation of the p16 INK4a gene was not found in these tumours ( Figure 3) . Hypermethylation of the p15
INK4b gene in DLF2 and DLF8 were also con®rmed by XhoI and SacII digestion (Figure 3b ). The methylation status of both p16
INK4b genes was normal in all 31 BDinduced lymphomas. INK4b genes in both ddC-induced lymphomas and BDinduced lymphomas. +, presence of the expected fragment when the blot was hybridized with the probe covering the respective exon; 7, absence of the expected fragment; 7/+, absence of the expected fragment and appearance of a novel smaller fragment
Analysis of point mutations of p16
INK4b
genes by single strand conformation analysis and direct DNA sequencing
In our previous study (Zhuang et al., 1996) , four of 16 (25%) ddC-induced lymphomas and seven of 31 (23%) BD-induced lymphomas displayed LOH in the chromosome 4 region containing the p16 INK4a and p15
INK4b loci. To investigate if another allele of these genes is inactivated by point mutation, tumours with LOH on chromosome 4 were examined by single strand conformation analyses and direct DNA sequencing (Table 1) . Based on the published sequences (Malumbres et al., 1997; Quelle et al., 1995a) , no alteration was observed except a base transition in codon 51 of p16 INK4a exon 2. Three strains (BALB/CJ, C3H/HeJ and CBA/J) displayed the ATA sequence, while the previously described GTA allele was found in the other nine strains (Figure 4 ). These ddC-and BDinduced lymphomas did not exhibit preferential LOH for either parental allele on chromosome 4 (Zhuang et al., 1996) . Likewise, a review of the literature (Sado et al., 1985; Ishizaka and Lilly, 1989; Angel et al., 1989; Drinkwater and Bennett, 1991; Harris and Lawley, 1994) does not indicate any obvious strain dierences in lymphoma susceptibility that correspond to the strain distribution pattern observed for these variants of p16
INK4a
-a codon 51 or p16
-b codon 72. Thus, these variants are likely to represent neutral polymorphisms rather than predisposing mutations.
Discussion
Structural genetic analysis of p16
INK4a and p15 INK4b genes showed homozygous deletions and rearrangements in four of 16 ddC-induced lymphomas (25%) and two of 31 BD-induced lymphomas. Surprisingly, while other exons of p16
INK4a and p15 INK4b genes were retained, two of these four ddC-induced lymphomas (DLF13 and DLF14) lost E1b exclusively. Another tumour (DLF15) revealed a deletion including the complete E1b exon and sequences near the p15
INK4b exon 2, suggesting that functional loss of p19 ARF is involved in INK4a was divided into two overlapping products by two pairs of primers, with MTS1F and MTS1R for 5' portion and MTS1F2 and MTS1R2 for 3' portion of exon 2 -a gene losses (Jen et al., 1994; Flores et al., 1996; Heyman et al., 1996) . Sequencing analysis of 24 tumour cell lines (Stone et al., 1995) and 50 primary tumours Fuero et al., 1996; Herman et al., 1996 Herman et al., , 1997 Batova et al., 1997; Malumbres et al., 1997) . In this study, two of 16 ddC-induced lymphomas (DLF2 and DLF8) showed abnormal methylation patterns in p15
INK4b genes, so it is plausible to assume a reduced level of p15
INK4b transcription in these two ddC-induced lymphomas. Unfortunately, we were unable to examine p15 INK4b transcript levels due to limited tumour materials. Interestingly, no hypermethylation of p16
INK4a was observed in either ddC-induced lymphomas or BD-induced lymphomas. Hypermethylation as a mechanism to inactivate the p15
INK4b , but not p16
INK4a genes, has also been found in some human gliomas, acute myelogenous leukaemias and particularly T-cell acute lymphocytic leukaemias (Herman et al., 1996; Batova et al., 1997) . Neutron-or g-radiationinduced T-cell mouse lymphomas also show frequent hypermethylation of the p15 INK4b gene and many of these same tumours lack hypermethylation of the p16
INK4a gene (Malumbres et al., 1997) . Structural alterations of p15 INK4b have been found predominantly in T-cell malignancies of both human and mice (Jen et al., 1994; Rasool et al., 1995; Sibert et al., 1995; Linardopoulos et al., 1997; Heyman et al., 1996; Herman et al., 1996 Herman et al., , 1997 Batova et al., 1997; Malumbres et al., 1997) . In the murine T-cell lymphomas we examined, both p15
INK4b and p16 INK4a -b were aected. It has been demonstrated that expression levels of p15
INK4b and p16 INK4a -b but not p16
INK4a
-a are dramatically altered after the activation of quiescent lymphocytes (Lois et al., 1995; Stone et al., 1995) . In addition, p15
INK4b is also transcriptionally induced by TGF-b, which acts as a potent growth inhibitor of hematopoietic stem cells and early progenitors (Hooper, 1991) . Thus, the p15 and p19 ARF proteins might be involved in the control of T-cells proliferation, suggesting that mutations of p15
INK4b or p16
-b genes may allow unrestrained growth of lymphoid cells.
In contrast to ddC-induced lymphomas, homozygous deletions involving the p15
INK4b and p16 INK4a genes occured only in two of 31 BD-induced lymphomas (6.5%), indicating that these alterations are rare in lymphomas induced by this chemical. Interestingly, in our previous study (Zhuang et al., 1997) , frequent genetic alterations of p53 tumour suppressor gene and ras proto-oncogenes were found in BD-induced but not ddC-induced lymphomas. Furthermore, a speci®c codon 13 GGC to CGC mutation in K-ras gene was found only in BD-induced lymphomas, whereas no mutation in codon 13 was observed in ddC-induced lymphomas. Considering that BD is mutagenic (IARC, 1992) and ddC acts as DNA terminator and inhibitor of reverse transcriptase (Starnes and Cheng, 1987) , the mechanisms of action for BD and ddC are quite dierent, therefore it is reasonable to suggest that dierent genetic pathways are targeted in the development of BD-and ddC-induced lymphomas. Malumbres et al. (1997) also reported lack of p15
INK4b
and p16
INK4a
inactivation in MNU-induced lymphomas that frequently contain ras mutations (Newcomb et al., 1988) , supporting the contention of agent-related genetic alterations during murine lymphomagenesis.
In summary, we have demonstrated that inactivations of the p15
INK4b and p16
-b genes are common genetic alterations in some chemically induced lymphomas. These observations support tumour suppressor activity as a function of the p15 and p19 ARF proteins in murine lymphomagenesis.
Materials and methods
Tumour induction and DNA isolation
Tumours were induced in B6C3F1 mice by long term inhalation of 20 ± 625 p.p.m. of BD in a study by Melnick et al. (1990) and by gavage of 1000 mg/kg/day of ddC for 3 ± 6 months . B6C3F1 mice were derived by crossing C57BL/6 females with C3H/He males. Lymphomas were of T-cell origin and collected mainly from thymus and spleens. Isolation of these tumour DNAs has been described previously (Zhuang et al., 1996) . Normal tissue DNAs from dierent mouse strains including 129/J, AKR/J, BALB/cJ, C3H/HeJ, C57BL/6J, C57L/J, CBA/J, DBA/2J, RF/J, SJL/J, ST/bJ and SWR/J were purchased from Jackson Laboratory (Bar Harbor, Maine).
Analysis of point mutations
Mouse exon 1 (E1a and E1b) and 2 of p16
INK4b
were ampli®ed by PCR using the primers listed in Table 1 . PCR reaction conditions with these primers include an annealing temperature of 558C, 2 mM MgCl 2 and 10% DMSO. Single strand conformaton analyses and direct DNA cycle sequencing using the dideoxy chain termination method were performed as described previously (Zhuang et al., 1997) .
Analysis of homozygous deletion and hypermethylation
DNA probes for Southern analyses were prepared by PCR from normal B6C3F1 genomic DNA using the primers listed in Table 1 . Primers MTS1F and MTS1R2 were used for the p16 INK4a exon 2 probe. These PCR products were puri®ed with the Wizard PCR Preps DNA system (Promega, Madison, WI) and labelled with a-32 P-dATP (3000 Ci/mmol, Amersham Life Science, Buckinghamshire) using a Prime-It II Random Primer Labelling Kit (Stratagene, La Jolla, CA).
To detect homozygous deletions, 10 mg of genomic DNAs were digested with 50 units of BamHI (Amersham Life Science), electrophoresed through 0.9% agarose gels, transferred to GeneScreen Plus membranes (Du Pont Inc. Boston, MA) by PosiBlot TM Pressure Blotter (Stratagene), and ®xed by U.V. crosslinking (Stratalinker 2400, Stratagene). Membranes were prehybridized for at least 4 h, hybridized to a 32 P-labeled p16
INK4a exon 2 probe at 508C for 20 h, and washed sequentially with 26SSC/1%SDS, 16SSC/1%SDS and 0.26SSC/1%SDS at 658C. Membranes were then exposed to a BAS III Imaging Plate (Fuji Photo Film Co., Minami-ashigara, Japan), which was subsequently read with a Fujix BAS1000 laser image analyser (Fuji Photo Film Co.). The same ®lters were stripped and rehybridized sequentially with 32 P-labelled probes for exon 1 and 2 of p15
INK4b
, exon E1a, exon E1b and ®nally exon 2 of p16 INK4a again. Because the speci®c band exist in every sample when the blots were hybridized with probe p16
INK4a exon 2, thus it was used as control of loading amount of DNA. It was classi®ed as deletion if the expected gene fragment was absent but there was speci®c band existed when the same blot was hybridized with the probe p16
INK4a exon 2. To assess the methylation status of the p16
INK4a gene, 10 mg of genomic DNA was digested with SpeI (Amersham Life Science) alone or SpeI and the methylation-sensitive restriction enzyme XhoI (Promega). These restriction digests were resolved on 1.5% agarose gels. The DNA transfer, hybridization, washing, and analysis were as described above except that only exon E1a of p16
INK4a was used as probe. Digestion with PstI (New England Biolabs, Hartfordshire) or PstI plus EagI (New England Biolabs) were applied to monitor methylation status of the p15
INK4b gene with p15
INK4b exon 1 as the probe. Hypermethylation results were con®rmed in three independent experiments. Tumour DNA samples showing p15 INK4b hypermethylation were also digested with EcoRI, EcoRI plus SacII and EcoRI plus XhoI to con®rm these results.
